On 14 October 2020, Tesserent CEO, Julian Challingsworth presented at IR Department’s virtual investor conference, IRD Invest, an event designed to bring investors directly to the CEOs of emerging ASX listed companies.

On 14 October 2020, Oventus CEO, Dr Chris Hart, presented at IR Department’s virtual investor conference, IRD Invest, an event designed to bring investors directly to the CEOs of emerging ASX listed companies.

Our client, ASX-listed oncology company Kazia Therapeutics Ltd (ASX: KZA; NASDAQ: KZIA, has had a huge few months, including the achievement of significant milestones for lead drug candidate, paxalisib.

We're all starting to think about AGMs (in fact, the IR Department team has already supported clients through a few! As companies are often running virtual AGMs for the first time this year, our friends at IRM have put together some thoughts on the corporate website can be a great tool to support shareholders with understanding how to join and vote. Thanks to the team at IRM for allowing us to share this post.